Oriental Carbon and Chemicals (OCCL) Q4 14/15 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 14/15 earnings summary
2 Nov, 2026Executive summary
FY15 standalone net sales rose 8% to ₹28,257.35 lakh; PAT increased to ₹5,131.60 lakh from ₹4,043.91 lakh, and the audit opinion was unqualified.
Consolidated PAT attributable to the holding company was ₹4,829.08 lakh, versus ₹4,048.79 lakh; diluted EPS was ₹46.90 versus ₹39.32.
Financial highlights
Standalone net revenue from operations was ₹28,257.35 lakh versus ₹26,169.57 lakh; total revenue was ₹29,543.48 lakh versus ₹26,518.57 lakh.
Standalone EBITDA was ₹8,414.21 lakh versus ₹7,164.05 lakh; PBT rose to ₹6,296.21 lakh from ₹5,015.50 lakh, and PAT to ₹5,131.60 lakh from ₹4,043.91 lakh.
Standalone basic and diluted EPS increased to ₹49.84 from ₹39.28; net worth was ₹24,354 lakh versus ₹20,275 lakh.
Consolidated net revenue from operations was ₹34,680.25 lakh versus ₹33,081.96 lakh; PAT attributable to the holding company was ₹4,829.08 lakh versus ₹4,048.79 lakh.
Standalone operating cash flow was ₹6,996.97 lakh versus ₹5,153.29 lakh; closing cash and cash equivalents rose to ₹1,251.70 lakh from ₹550.12 lakh.
Outlook and guidance
Both Insoluble Sulphur plants were fully committed; production was expected to reach optimum installed capacity, with Mundra expansion under exploration.
Global Insoluble Sulphur demand was forecast to grow 3–4% annually; domestic demand was expected to grow at double-digit rates, supported by commercial-vehicle tyre radialisation.
Growth plans included broadening customer and geographic reach, particularly in China and the US, and potentially adding production lines at Mundra.
Sulphuric Acid and Oleum prospects remained constrained by commodity pricing and subdued fertilizer demand; weak rains and subsidy conditions were expected to weigh on acid demand.
Latest events from Oriental Carbon and Chemicals
- Profitable growth and a ₹216 crore expansion plan advance the next capacity phase.OCCL
Q4 18/19 - COVID-19 hit FY20 results; FY21 outlook signaled lower sales and delayed expansion.OCCL
Q4 19/20 - Higher FY18 profit and expanding Insoluble Sulphur capacity underpin the growth outlook.OCCL
Q4 17/18 - Higher margins lifted PAT despite weaker sales; Mundra expansion was due in April 2017.OCCL
Q4 15/16 - Mundra expansion and Insoluble Sulphur growth drive the FY2016-17 outlook.OCCL
Q4 16/17 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - Sales rose, but lower tyre demand and higher costs cut earnings as Mundra Phase II ramped up.OCCL
Q4 12/13 - FY11 profit rose as capacity expansion targeted strong Insoluble Sulphur demand.OCCL
Q4 10/11 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12